Helping Save Lives through Cord Blood

The Cleveland Cord Blood Center is an independent, public cord blood bank. Since its founding in 2008, the not-for-profit 501(c)(3) collects, processes, stores and distributes stem-cell rich umbilical cord blood for transplantation in patients with life threatening disorders such as leukemia, lymphoma and immune system disorders. In addition, CCBC researchers are exploring the use of cord blood-derived cells as regenerative cell therapies to address unmet medical needs. The Cleveland Cord Blood Center was founded by Mary J. Laughlin, M.D., who performed one of the world’s first successful umbilical cord blood stem cell transplants on an adult leukemia patient in 1995.

This is the flash breakout area. If you're seeing this text there was likely a problem loading or you do not have the Flash plugin installed.

 

In The News

FDA Approves the Cleveland Cord Blood Center’s CLEVECORD™
for Stem Cell Transplants


CLEVELAND, Ohio—September 12, 2016—The U.S. Food and Drug Administration (FDA) has issued a biologics license to the Cleveland Cord Blood Center (CCBC) for CLEVECORD™, a stem cell product (HPC, Cord Blood) derived from umbilical cord blood. Under this license, CCBC is authorized to manufacture CLEVECORD for use in unrelated hematopoietic cell transplantation in patients with disorders affecting the hematopoietic system such as leukemia, lymphoma and immune system disorders... (Read more)